advertisement

WGA Rescources

Abstract #47945 Published in IGR 13-4

Corneal endothelial cell changes after Ahmed(trademark) valve and Molteno(trademark) glaucoma implants

Nassiri N; Majdi-N M; Salehi M; Panahi N; Djalilian AR; Peyman GA
Ophthalmic Surgery Lasers and Imaging 2011; 42: 394-399


(black square) BACKGROUND AND OBJECTIVE: Changes in corneal endothelial cell (CEC) indices 24 months after Ahmed valve (New World Medical, Inc., Rancho Cucamonga, CA) and single-plate Molteno implants (Molteno Ophthalmic Limited, Dunedin, New Zealand) were evaluated. (black square) PATIENTS AND METHODS: This cohort included Ahmed valve (29 eyes) or single-plate Molteno (28 eyes) implants. Preoperative and postoperative central CEC indices were compared. Main outcome measure was endothelial cell count. (black square)RESULTS: Twenty-four months postoperatively, no difference in visual acuity improvement or decrease in antiglaucoma medications was observed between groups. The Molteno group showed better postoperative intraocular pressure control (P < .001). An 11.52% (Ahmed) and 12.37% (Molteno) reduction in CEC density (cells/mm(2)) and 3.78 (Ahmed) and 2.48 (Molteno) increase in CEC area (mm(2)) was observed, but no significant between-group difference in CEC density and area or corneal thickness. (black square) CONCLUSION: Twenty-four months after Ahmed valve or Molteno implant, statistically significant quantitative (cell density) and minor qualitative (cell area) changes in central CEC were observed. Both groups appeared to have similar CEC damage. Copyright (copyright) SLACK Incorporated.

G.A. Peyman. 10650 W. Tropicana Circle, Sun City, AZ 85351, United States. Email: gpeyman1@yahoo.com


Classification:

12.8.2 With tube implant or other drainage devices (Part of: 12 Surgical treatment > 12.8 Filtering surgery)
12.8.11 Complications, endophthalmitis (Part of: 12 Surgical treatment > 12.8 Filtering surgery)



Issue 13-4

Change Issue


advertisement

Oculus